| NaturNorth Technologies LLC, a USA business, has patented a process to isolate betulin and other compounds from birch bark for use in medicines and cosmetics, and is looking at the potential for them as treatments for skin cancer and human immunodeficiency virus (HIV). A Russian company, Birch World Ltd, already supplies similar birch bark derivatives to Asian and European medicine and cosmetics markets. |
